<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>M. Oresic | YZ Lab</title>
    <link>https://yz-lab.org/main/authors/m.-oresic/</link>
      <atom:link href="https://yz-lab.org/main/authors/m.-oresic/index.xml" rel="self" type="application/rss+xml" />
    <description>M. Oresic</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Fri, 01 May 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://yz-lab.org/main/media/icon_hued1f538d73f883b5373c8a98edb20792_18869_512x512_fill_lanczos_center_3.png</url>
      <title>M. Oresic</title>
      <link>https://yz-lab.org/main/authors/m.-oresic/</link>
    </image>
    
    <item>
      <title>The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue</title>
      <link>https://yz-lab.org/main/publication/refworks1475/</link>
      <pubDate>Fri, 01 May 2020 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1475/</guid>
      <description>&lt;p&gt;LR: 20200518; CI: (c) 2020; GR: Novo Nordisk Foundation; GR: EU H2020-JTI-IMI2 project 777377-2 Liver Investigation: Testing Marker Utility in Steatohepatitis; GR: FS/15/56/31645/BHF_/British Heart Foundation/United Kingdom; GR: 634413/EU H2020 project &amp;lsquo;Elucidating Pathways of Steatohepatitis&amp;rsquo;; GR: Sigrid Juselius Foundation; GR: EVO; GR: 309263/Academy of Finland; JID: 101160857; OTO: NOTNLM; 2020/04/02 00:00 [received]; 2020/04/23 00:00 [revised]; 2020/05/02 00:00 [accepted]; 2020/05/10 06:00 [pubmed]; 2020/05/10 06:00 [medline]; 2020/05/10 06:00 [entrez]; aheadofprint&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids</title>
      <link>https://yz-lab.org/main/publication/refworks1467/</link>
      <pubDate>Thu, 01 Aug 2019 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1467/</guid>
      <description>&lt;p&gt;LR: 20191023; JID: 101676073; OTO: NOTNLM; 2019/02/01 00:00 [received]; 2019/07/16 00:00 [accepted]; 2019/08/23 06:00 [entrez]; 2019/08/23 06:00 [pubmed]; 2019/08/23 06:00 [medline]; epublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars</title>
      <link>https://yz-lab.org/main/publication/refworks1444/</link>
      <pubDate>Wed, 01 Aug 2018 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1444/</guid>
      <description>&lt;p&gt;LR: 20180723; CI: (c) 2018; ClinicalTrials.gov/NCT02133144; JID: 7805975; 2018/01/11 00:00 [received]; 2018/05/01 00:00 [accepted]; 2018/05/31 06:00 [pubmed]; 2018/05/31 06:00 [medline]; 2018/05/31 06:00 [entrez]; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD</title>
      <link>https://yz-lab.org/main/publication/refworks1426/</link>
      <pubDate>Sat, 01 Jul 2017 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1426/</guid>
      <description>&lt;p&gt;LR: 20170619; CI: Copyright (c) 2017; JID: 8503886; OTO: NOTNLM; 2016/11/28 [received]; 2017/02/07 [revised]; 2017/02/10 [accepted]; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans</title>
      <link>https://yz-lab.org/main/publication/refworks1417/</link>
      <pubDate>Thu, 01 Dec 2016 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1417/</guid>
      <description>&lt;p&gt;LR: 20161119; JID: 8503886; 2016/06/30 [received]; 2016/07/22 [revised]; 2016/07/26 [accepted]; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites</title>
      <link>https://yz-lab.org/main/publication/refworks1407/</link>
      <pubDate>Sat, 01 Oct 2016 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1407/</guid>
      <description>&lt;p&gt;CI: Copyright (c) 2016; JID: 101160775; OTO: NOTNLM; 2016/01/25 [received]; 2016/05/05 [revised]; 2016/05/16 [accepted]; 2016/06/16 [aheadofprint]; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease</title>
      <link>https://yz-lab.org/main/publication/refworks1402/</link>
      <pubDate>Sun, 01 May 2016 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1402/</guid>
      <description>&lt;p&gt;CI: Copyright (c) 2016; JID: 8503886; OTO: NOTNLM; 2015/07/28 [received]; 2015/11/05 [revised]; 2016/01/04 [accepted]; 2016/01/11 [aheadofprint]; ppublish&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2</title>
      <link>https://yz-lab.org/main/publication/refworks1387/</link>
      <pubDate>Sun, 01 Mar 2015 00:00:00 +0000</pubDate>
      <guid>https://yz-lab.org/main/publication/refworks1387/</guid>
      <description>&lt;p&gt;CI: Copyright (c) 2014; JID: 8503886; OTO: NOTNLM; 2014/05/09 [received]; 2014/08/04 [revised]; 2014/10/06 [accepted]; 2014/10/19 [aheadofprint]; ppublish&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
